I think we’re watching a paradigm shift in radiation oncology. This stuff will eventually render a lot of external beam treatment obsolete. Whichever company (may not be this one) that gets first mover advantage in this sphere is going to do really really well, so seeing an announcement like this is more positive to me than any specific trial result could ever be.
I think we’re watching a paradigm shift in radiation oncology....
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.004(11.1%) |
Mkt cap ! $18.07M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 4.4¢ | 3.8¢ | $42.78K | 1.063M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 75000 | 2 |
View Market Depth
| Last trade - 15.56pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.1¢ |
Change
0.004 ( 10.8 %) |
||||
| Open | High | Low | Volume | ||
| 3.8¢ | 4.4¢ | 3.8¢ | 166152 | ||
| Last updated 15.56pm 03/05/2024 ? | |||||
| RAD (ASX) Chart |